header advert
Results 1 - 4 of 4
Results per page:
Orthopaedic Proceedings
Vol. 103-B, Issue SUPP_6 | Pages 49 - 49
1 May 2021
Gigi R Kurien B Giles S Fernandes J
Full Access

Introduction

The purpose of our study was to retrospectively analyze our patients who were treated for FH and PFFD by means of guided growth temporary Hemiepiphysiodesis.

We sought to determine the effectiveness of the procedure, as well as its success rates, complications, and rebound phenomena.

Materials and Methods

We retrospectively reviewed the medical records and all routine preoperative and post operative long standing radiograph of all the FH and PFFD patients that were operated in our institute using guided growth hemiepiphysiodesis technique of distal femur or proximal tibia between 2007 to 2017.


Orthopaedic Proceedings
Vol. 103-B, Issue SUPP_6 | Pages 50 - 50
1 May 2021
Segev E Mor Y Inbar L Ovadia D Gigi R
Full Access

Introduction

Several hexapod external fixator devices are used in the treatment of bone fracture and deformity corrections. One characteristic of all of them is the requirement for manual adjustment of the fixator struts. The purpose of this study was to introduce a novel robotic system that executes automatic adjustment of the struts.

Materials and Methods

Ten patients were treated for various bone deformities using a hexapod external fixator with Auto Strut system, which implemented automatic adjustment of the fixator struts. Patients arrived at the clinic for follow during the correction period until the removal of the hardware. During each visit, the progress of the correction was assessed (clinically and radiographically) and reading of the strut scale numbers was performed.


Orthopaedic Proceedings
Vol. 103-B, Issue SUPP_6 | Pages 47 - 47
1 May 2021
Gigi R Gorrtzak Y Golden E Gabay R Rumack N Yaniv M Dadia S Segev E
Full Access

Introduction

Patient-specific instruments (PSI) and surgical-guiding templates are gaining popularity as a tool for enhancing surgical accuracy in the correction of oblique bone deformities Three-dimensional virtual surgical planning technology has advanced applications in the correction of deformities of long bones and enables the production of 3D stereolithographic models and PSI based upon a patient's specific deformity. We describe the implementation of this technology in young patients who required a corrective osteotomy for a complex three-plane (oblique plane) lower-limb deformity.

Materials and Methods

Radiographs and computerized tomographic (CT) scans (0.5 mm slices) were obtained for each patient. The CT images were imported into post-processing software, and virtual 3D models were created by a segmentation process. Femoral and tibial models and cutting guides with locking points were designed according to the deformity correction plan as designed by the surgeon. The models were used for preoperative planning and as an intraoperative guide. All osteotomies were performed with the PSI secured in the planned position.


The Bone & Joint Journal
Vol. 95-B, Issue 11 | Pages 1575 - 1580
1 Nov 2013
Salai M Somjen D Gigi R Yakobson O Katzburg S Dolkart O

We analysed the effects of commonly used medications on human osteoblastic cell activity in vitro, specifically proliferation and tissue mineralisation. A list of medications was retrieved from the records of patients aged > 65 years filed in the database of the largest health maintenance organisation in our country (> two million members). Proliferation and mineralisation assays were performed on the following drugs: rosuvastatin (statin), metformin (antidiabetic), metoprolol (β-blocker), citalopram (selective serotonin reuptake inhibitor [SSRI]), and omeprazole (proton pump inhibitor (PPI)). All tested drugs significantly stimulated DNA synthesis to varying degrees, with rosuvastatin 5 µg/ml being the most effective among them (mean 225% (sd 20)), compared with metformin 10 µg/ml (185% (sd 10)), metoprolol 0.25 µg/ml (190% (sd 20)), citalopram 0.05 µg/ml (150% (sd 10)) and omeprazole 0.001 µg/ml (145% (sd 5)). Metformin and metoprolol (to a small extent) and rosuvastatin (to a much higher extent) inhibited cell mineralisation (85% (sd 5)). Our results indicate the need to evaluate the medications prescribed to patients in terms of their potential action on osteoblasts. Appropriate evaluation and prophylactic treatment (when necessary) might lower the incidence and costs associated with potential medication-induced osteoporosis.

Cite this article: Bone Joint J 2013;95-B:1575–80.